计量剂量吸入器与急性喘恶化的雾化器治疗:一个过程评估
Christopher Graybill1, Colleen Paramesh2, Jason Gray2
1The University of Kansas School of Nursing, Kansas City, KS, USA cgraybill79@gmail.com.
Journal of doctoral nursing practice
|November 13, 2024
概括
带有间隔器的计量剂量吸入器 (MDIs) 证明在儿童喘恶化中比雾化器更有效. 这种方法在30天内减少了对诊所的复诊和急诊室的访问.
科学领域:
- 儿科肺病学 儿科肺病学
- 公共卫生 公共卫生
- 医疗保健管理的管理
背景情况:
- 儿童喘影响6.5%的美国儿童.
- 在COVID-19大流行期间,一个联邦合格卫生中心 (FQHC) 从雾化阿尔布特罗尔转向带间隔器的计量剂量吸入器 (MDIs).
- 这一变化旨在最大限度地减少病原体的气溶和降低医疗保健成本.
研究的目的:
- 评估切换喘恶化治疗方案的安全性,有效性和效率.
- 为了在儿科患者中比较 nebulized albuterol 与 MDIs 与间隔器.
主要方法:
- 对患有喘恶化症的儿科患者的回顾性图表审查.
- nebulized albuterol 与使用间隔剂的 MDI 的比较.
- 测量了30天返回护理率 (ED或诊所),总治疗次数和并发的口服类固醇使用.
主要成果:
- 随着MDIs,观察到30天返回诊所访问的统计学显著减少.
- 用MDI和间隔器治疗的零患者在30天内返回诊所.
- 接受 nebulized albuterol 治疗的患者中有 61% 在 30 天内复发 (p < .00001).
结论:
- 带有间隔器的Albuterol MDI在减少后续访问方面比雾化剂更有效.
- 这种MDI方法有效地减少了在30天内访问急诊室的次数.
- 在初级保健中使用MDIs治疗喘恶化是具有成本效益的,并减少了空气中的暴露.
相关概念视频
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
234
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
234
01:20Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
01:17Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353